SynthesisFrontiers in medicine2026
The effectiveness of Traditional Chinese Medicine in treating cancer related anemia: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim is to systematically evaluate the clinical efficacy of Traditional Chinese Medicine (TCM) in the treatment of cancer related anemia (CRA), and to provide higher quality evidence-based medical evidence for the treatment of CRA with TCM. Methods: Pubmed, Embase, Cochrane library, Scopus, Web of Science, China National Knowledge Infrastructure (CNKI), China Biology Medicine Disk (CBM) and WanFang were searched for the literature on TCM treatment of CRA included in the databases from the establishment of the databases to December 2025. Meta-analysis was performed using ReVman5.3 software. Results: 6,201 relevant literatures were retrieved. According to inclusion and exclusion criteria, a total of 58 literatures were included, with a total of 4,308 patients, including 2,157 patients in the treatment group and 2,151 patients in the control group. The treatment group was better than the control group in improving hemoglobin level, clinical efficacy, KPS score, TCM syndrome efficacy, TCM Syndrome Score, immune function and red blood cell count, the difference was statistically significant ( Conclusion: Traditional Chinese Medicine can significantly improve CRA, enhance TCM syndrome and immune function, and improve patients' quality of life. Clinical Trial Registration: https://www.chictr.org.cn, identifier [ChiCTR2300077699].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.